Michael Riebe

Michael Riebe is an accomplished professional in pharmaceutical development, currently serving as a Board Member for Respira Therapeutics, Inc. and Satsuma Pharmaceuticals, Inc. With extensive experience at AstraZeneca as Senior Director of Scientific Project Management and previously as Vice President of Inhalation Product Development, Riebe has consistently driven advancements in inhalation product technologies. Prior roles include Senior Vice President at Pearl Therapeutics and Vice President of R&D at iCeutica Inc., alongside significant positions at Merck, RTI International, and GlaxoSmithKline. Riebe holds a Ph.D. in Analytical Chemistry from the University of Wisconsin-Madison and a B.A. in Chemistry from Kalamazoo College.